{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:17:32Z","timestamp":1788542252353,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["PPA-0517-0717-RAD"],"award-info":[{"award-number":["PPA-0517-0717-RAD"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["PCT\/EP2020\/080429"],"award-info":[{"award-number":["PCT\/EP2020\/080429"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtn.2021.02.033","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T10:29:13Z","timestamp":1614594553000},"page":"274-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["AON-based degradation of c.151C>T mutant COCH transcripts associated with dominantly inherited hearing impairment DFNA9"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-3269","authenticated-orcid":false,"given":"Erik","family":"de Vrieze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ca\u00f1as Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-3518","authenticated-orcid":false,"given":"Jolien","family":"Peijnenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniek","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-4220","authenticated-orcid":false,"given":"Jaap","family":"Oostrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Neveling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-9683","authenticated-orcid":false,"given":"Ronald","family":"Pennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-8693","authenticated-orcid":false,"given":"Hannie","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-3460","authenticated-orcid":false,"given":"Erwin","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.02.033_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/hmg\/ddl022","article-title":"Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction","volume":"15","author":"Robertson","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.033_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/000348940311200316","article-title":"Cross-sectional analysis of hearing threshold in relation to age in a large family with cochleovestibular impairment thoroughly genotyped for DFNA9\/COCH","volume":"112","author":"Bom","year":"2003","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.omtn.2021.02.033_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fnins.2017.00735","article-title":"Does Otovestibular Loss in the Autosomal Dominant Disorder DFNA9 Have an Impact of on Cognition? A Systematic Review","volume":"11","author":"De Belder","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtn.2021.02.033_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjoto.2012.11.002","article-title":"Novel COCH mutation in a family with autosomal dominant late onset sensorineural hearing impairment and tinnitus","volume":"34","author":"Gallant","year":"2013","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.omtn.2021.02.033_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2019.02.001","article-title":"Cleaved Cochlin Sequesters Pseudomonas aeruginosa and Activates Innate Immunity in the Inner Ear","volume":"25","author":"Jung","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2021.02.033_bib6","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.febslet.2008.10.050","article-title":"The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens","volume":"582","author":"Nagy","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2021.02.033_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/hmg\/8.2.361","article-title":"A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects","volume":"8","author":"de Kok","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.033_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jmg.38.1.61","article-title":"A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutation","volume":"38","author":"Fransen","year":"2001","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtn.2021.02.033_bib9","doi-asserted-by":"crossref","first-page":"14909","DOI":"10.1074\/jbc.M110.106724","article-title":"Role of protein misfolding in DFNA9 hearing loss","volume":"285","author":"Yao","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2021.02.033_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.heares.2010.11.002","article-title":"Hearing and vestibular deficits in the Coch(-\/-) null mouse model: comparison to the Coch(G88E\/G88E) mouse and to DFNA9 hearing and balance disorder","volume":"272","author":"Jones","year":"2011","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtn.2021.02.033_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41431-017-0066-2","article-title":"Bi-allelic inactivating variants in the COCH gene cause autosomal recessive prelingual hearing impairment","volume":"26","author":"JanssensdeVarebeke","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2021.02.033_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-4781(99)00148-7","article-title":"Molecular mechanisms of action of antisense drugs","volume":"1489","author":"Crooke","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2021.02.033_bib13","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1093\/nar\/gkv920","article-title":"The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA","volume":"43","author":"Vickers","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.033_bib14","doi-asserted-by":"crossref","first-page":"e108625","DOI":"10.1371\/journal.pone.0108625","article-title":"Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms","volume":"9","author":"Vickers","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2021.02.033_bib15","doi-asserted-by":"crossref","first-page":"eaar3959","DOI":"10.1126\/scitranslmed.aar3959","article-title":"Huntingtin suppression restores cognitive function in a mouse model of Huntington\u2019s disease","volume":"10","author":"Southwell","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2021.02.033_bib16","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.4161\/cc.7.16.6461","article-title":"Insights into RNA\/DNA hybrid recognition and processing by RNase H from the crystal structure of a non-specific enzyme-dsDNA complex","volume":"7","author":"Pallan","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omtn.2021.02.033_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/mt.2008.205","article-title":"Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms","volume":"17","author":"Aartsma-Rus","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.033_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/978-1-4939-8651-4_34","article-title":"Antisense Oligonucleotide Design and Evaluation of Splice-Modulating Properties Using Cell-Based Assays","volume":"1828","author":"Slijkerman","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2021.02.033_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/bi962230p","article-title":"Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids","volume":"36","author":"Lima","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2021.02.033_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtn.2021.02.033_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/genes10050363","article-title":"Antisense Oligonucleotide-Based Downregulation of the G56R Pathogenic Variant Causing NR2E3-Associated Autosomal Dominant Retinitis Pigmentosa","volume":"10","author":"Naessens","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omtn.2021.02.033_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.118.036965","article-title":"Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain Mutation","volume":"140","author":"Zaleta-Rivera","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2021.02.033_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.1236921","article-title":"Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy","volume":"342","author":"Jiang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2021.02.033_bib24","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In\u00a0vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.033_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/humu.22701","article-title":"Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder","volume":"35","author":"Bae","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2021.02.033_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1162986","article-title":"Real-time DNA sequencing from single polymerase molecules","volume":"323","author":"Eid","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtn.2021.02.033_bib27","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.033_bib28","first-page":"531210","article-title":"Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes","volume":"42","author":"Karczewski","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2021.02.033_bib29","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1074\/jbc.M210326200","article-title":"Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis","volume":"278","author":"Vickers","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2021.02.033_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/nat.2015.0547","article-title":"Allele-Selective Inhibition of Mutant Huntingtin with 2-Thio- and C5- Triazolylphenyl-Deoxythymidine-Modified Antisense Oligonucleotides","volume":"25","author":"\u00d8stergaard","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2021.02.033_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic Oligonucleotides: State of the Art","volume":"59","author":"Smith","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtn.2021.02.033_bib32","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1101\/gr.1006603","article-title":"Allelic variation in gene expression is common in the human genome","volume":"13","author":"Lo","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2021.02.033_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00405-019-05322-x","article-title":"A systematic review of hearing and vestibular function in carriers of the Pro51Ser mutation in the COCH gene","volume":"276","author":"JanssensdeVarebeke","year":"2019","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.omtn.2021.02.033_bib34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/01.mao.0000185048.84641.e3","article-title":"Vestibular deterioration precedes hearing deterioration in the P51S COCH mutation (DFNA9): an analysis in 74 mutation carriers","volume":"26","author":"Bischoff","year":"2005","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.omtn.2021.02.033_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ydbio.2014.03.023","article-title":"Canonical Wnt signaling regulates the proliferative expansion and differentiation of fibrocytes in the murine inner ear","volume":"391","author":"Bohnenpoll","year":"2014","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtn.2021.02.033_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nm.3106","article-title":"Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness","volume":"19","author":"Lentz","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2021.02.033_bib37","doi-asserted-by":"crossref","first-page":"107931","DOI":"10.1016\/j.heares.2020.107931","article-title":"Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction","volume":"394","author":"Hastings","year":"2020","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtn.2021.02.033_bib38","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1523\/JNEUROSCI.22-05-01718.2002","article-title":"Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness","volume":"22","author":"Delprat","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2021.02.033_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2018.06.018","article-title":"Local drug delivery to the inner ear: Principles, practice, and future challenges","volume":"368","author":"Plontke","year":"2018","journal-title":"Hear. Res."},{"key":"10.1016\/j.omtn.2021.02.033_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MOO.0000000000000566","article-title":"State-of-the-art methods in clinical intracochlear drug delivery","volume":"27","author":"Chin","year":"2019","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.omtn.2021.02.033_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2018.05.020","article-title":"Inner ear drug delivery: Recent advances, challenges, and perspective","volume":"126","author":"Hao","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2021.02.033_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2105-11-129","article-title":"RNAstructure: software for RNA secondary structure prediction and analysis","volume":"11","author":"Reuter","year":"2010","journal-title":"BMC Bioinformatics"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:49:10Z","timestamp":1788540550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"alternative-id":["S2162253121000688"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.02.033","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AON-based degradation of c.151C>T mutant COCH transcripts associated with dominantly inherited hearing impairment DFNA9","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}